Single Cell Protein Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Single Cell Protein Market Trends and Insights

Rising demand for alternative protein sources

Population growth and shifting dietary preferences are widening the global protein gap, and single-cell protein offers a land- and water-efficient solution that fits national food-security agendas in China, India, and Singapore. Import-reliant economies view microbial protein as a hedge against soybean and fishmeal volatility, while leading producers such as Angel Yeast and Calysta are reaching cost parity with traditional feed proteins at scale. Angel Yeast's AngeoPro yeast protein, with 96% protein utilization and 47% essential amino acid content, is positioned to substitute whey and soy in protein bars, cereals, and alternative meats. Singapore's Food Agency approved multiple mycoprotein and precision-fermented ingredients in 2024, enabling rapid commercialization in a market targeting 30% nutritional self-sufficiency by 2030^{[1]Source: Singapore Food Agency, "Singapore Food Statistics 2024", sfa.gov.sg}. The convergence of food-security mandates, import-substitution policies, and consumer willingness to adopt blended meat products is accelerating procurement by multinational food companies and regional brands.

Sustainability and environmental concerns

Life-cycle studies indicate that microbial protein can cut greenhouse-gas emissions by up to 97% relative to beef, attracting companies racing to meet science-based targets. EU farm-to-fork strategies favor low-emission ingredients, and the European Food Safety Authority's 2025 positive opinion for Fermotein illustrates momentum toward carbon-negative proteins in the mainstream food supply. Steel mills and refineries are piloting LanzaTech’s CO₂-to-protein modules, turning pollution into revenue while earning carbon credits. Horizon-funded initiatives such as SynoProtein are validating forest-residue feedstocks, broadening the sustainability narrative, and strengthening the single-cell protein market. Regulatory frameworks such as the International Standard Organization's 2021 revision of "protein fibre" definitions to include synthetically produced proteins are formalizing microbial protein as a recognized ingredient category, reducing approval friction and enabling corporate sustainability commitments to translate into procurement mandates.

Expansion of aqua-/animal feed and pet-food industry

Aquaculture alone will require an extra 100 million tonnes of feed protein by 2050, and microbial alternatives with superior digestibility are already filling premium niches. Calysta’s 20,000-tonne FeedKind facility in China supplies both aquafeed and pet-food makers, while United States pet owners spend more on hypoallergenic formulations that highlight sustainable protein sources, which are gaining traction in premium pet food formulations, with NovoNutrients shifting focus toward pet food adoption due to faster regulatory pathways and higher willingness to pay. The Better Meat Co. secured Singapore Food Agency approval for Rhiza mycoprotein in October 2024 and holds a commercial collaboration with Perdue Farms for "Chicken Plus" hybrid products in the United States, demonstrating how single-cell protein can reduce meat content while maintaining sensory attributes and improving margin structure.

Advancements in precision-fermentation technology

Precision fermentation is enabling the production of functional proteins with Protein Digestibility Corrected Amino Acid Score (PDCAAS) scores of 1.0, matching or exceeding whey and casein benchmarks, and regulatory approvals are accelerating commercialization timelines. The United States Food and Drug Administration (U.S. FDA) issued Generally Recognized As Safe (GRAS) letters for All G's bovine lactoferrin and Vivici's whey protein in 2024, demonstrating that precision fermentation can reach industrial productivity levels that reduce downstream processing costs and improve unit economics. Hydrogen-oxidizing bacteria platforms achieved 100% hydrogen efficiency in electrolytic gas-lift reactors, eliminating H₂ transfer losses and reducing explosion risk, with biomass productivity of 0.20 grams per liter per day and 58.3% protein content. These advances are compressing strain development cycles from years to months through high-throughput biofoundries and evolutionary engineering, enabling rapid customization of amino acid profiles for sports nutrition, infant formula, and elderly nutrition applications.

Competition from established soy/fishmeal proteins

Soybean meal remains the dominant protein source in livestock and aquafeed due to established supply chains, agronomic scale, and commodity pricing mechanisms. Single-cell protein must achieve cost parity or demonstrate superior functional performance (digestibility, amino acid profile, pathogen-free status) to displace incumbent ingredients in price-sensitive feed markets. Calysta's FeedKind positions itself competitively with fishmeal, but scaling beyond niche applications requires multi-year supply agreements and validation trials that delay market penetration. DSM-Firmenich's rainbow trout trials demonstrated that 20% single-cell protein inclusion performs comparably to fishmeal, yet feed formulators remain conservative in adopting novel ingredients without long-term performance data and regulatory clarity across export markets. The aquafeed market's CAGR through 2031, and single-cell protein's share will depend on securing anchor customers willing to absorb transition risk and co-invest in supply-chain integration.

Regulatory and consumer-acceptance hurdles

Novel food approval timelines in the European Union can exceed five years, and the Protein Brewery filed its Fermotein dossier over five years before receiving the European Food Safety Authority's positive opinion in 2025, with European Commission and member-state approval still pending. United States Food and Drug Administration (U.S. FDA) Generally Recognized As Safe (GRAS) processes vary in duration and stringency depending on self-affirmation versus "No Questions" letter pathways, and companies such as Verley and All G are pursuing both routes to accelerate market entry. The United States Food and Drug Administration (U.S. FDA) fragmented regulatory frameworks across Asia-Pacific jurisdictions create duplication of safety studies and delay regional launches, though Singapore's Food Agency has emerged as a first-mover market by approving multiple microbial proteins in 2024. Labeling requirements for genetically modified microorganisms and allergen declarations (e.g., beta-casein as a milk allergen) add compliance complexity and may trigger negative consumer perceptions in markets with low Genetically Modified Organisms (GMOs) acceptance.

Segment Analysis

By Source: Established Yeast Capacity Leads Amid Rapid Bacterial Gains

In 2025, yeast-based single-cell protein commanded a 41.96% market share, driven by several key developments in the industry. Angel Yeast's newly commissioned 11,000-tonne-per-year facility in Yichang (operational from November 2025) significantly contributed to this growth. Additionally, Quorn's mycoprotein production capacity, which is approximately 24,000 tonnes annually, and Lallemand's extensive global portfolio of yeast extracts and nutritional products further strengthened the segment's position. Yeast protein production benefits from a combination of factors, including decades of industrial fermentation expertise, a robust and well-established downstream processing infrastructure, and widespread consumer familiarity with yeast-derived ingredients.

Bacterial protein is rapidly emerging as the fastest-growing source segment, with a projected compound annual growth rate (CAGR) of 10.71% from 2026 to 2031. This remarkable growth is primarily driven by advancements in gas-fermentation platforms, which efficiently convert carbon dioxide (CO₂), methane, and hydrogen into high-protein biomass. A notable example of this innovation is NovoNutrients, which raised USD 18 million in Series A funding in July 2024, with Woodside Energy leading the investment. This funding aims to scale NovoNutrients' CO₂-to-protein technology. These developments highlight the growing potential of bacterial proteins as a sustainable and scalable alternative in the protein market.

By Application: Animal Feed Anchored by Aquaculture Economics

Animal feed and pet food applications commanded a 60.32% share in 2025, driven by aquaculture's global growth and pet food's premium pricing tolerance for hypoallergenic and sustainable ingredients. Calysta's FeedKind methanotrophic protein is operational at 20,000 tonnes per year in China and targets 70% market penetration in pet food protein, approaching cost parity with fishmeal in high-volume contracts. In animal feed, the proven nutritional equivalence and cost benefits are evident, with inclusion levels tailored between 10-80%, contingent on species needs and regulatory stipulations.

Food and beverage applications are expanding at an 11.82% CAGR from 2026 to 2031, supported by regulatory approvals for precision-fermented whey, mycoprotein, and yeast protein in sports nutrition, dairy alternatives, and hybrid meat products. Starbucks India and SuperYou launched protein cold foam in January 2026, embedding protein into familiar beverage formats to lower adoption barriers. Regulatory advancements further fuel this growth, highlighted by the European Food Safety Authority's (EFSA's)^{[2]Source: European Food Safety Authority, "Navigating Novel Foods to Europe in 2025: Insights into the Latest EFSA Guidance", efsa.europea.eu} updated guidance on novel foods, set to take effect in February 2025, which streamlines the approval process for microbial proteins

Geography Analysis

In 2025, Europe holds a 32.86% market share, reflecting its advanced regulatory frameworks and well-established industrial infrastructure. Countries such as the Netherlands are leading efforts with national protein strategies aimed at reducing import reliance and enhancing domestic microbial protein production. The region benefits from strong consumer acceptance of alternative proteins and sustainability-driven policies that support single-cell protein adoption. Key developments include EU approvals for novel protein sources and significant investments in fermentation capacity, such as Solar Foods' Factory01 in Finland, which produces 160 tons of Solein annually. However, Europe's growth rate lags behind that of the Asia-Pacific due to complex regulatory processes and the constraints of a mature market.

Asia-Pacific is the fastest-growing region, with an 11.91% CAGR projected through 2031. This growth is driven by China's advancements in biomanufacturing infrastructure and government support for protein fermentation. India's animal feed growth and consumption over recent years have also boosted market demand^{[3]Source: U.S Department of Agriculture 2025, "The Growing Demand for Animal Products and Feed in India: Future Prospects for Production, Trade, and Technology Innovation", ers.usda.gov}. Singapore has established itself as a regional innovation hub through its leadership in alternative protein regulatory approvals, enabling multiple companies to secure manufacturing licenses and novel food authorizations. Japan and South Korea are enhancing their precision fermentation capabilities through government programs and corporate investments, while Australia is implementing comprehensive strategies to commercialize alternative proteins.

North America benefits from a favorable regulatory environment and substantial venture capital investments. Companies have secured significant funding, such as NovoNutrients' USD 18 million Series A round, alongside multiple Generally Recognized as Safe (GRAS) approvals for microbial proteins. The region's dynamic innovation ecosystem fosters rapid commercialization through partnerships between biotech startups and established food companies. Meanwhile, South America and the Middle East and Africa are emerging as promising markets, driven by increasing protein demand and growing investment interest. For instance, Unibio secured USD 70 million from the Saudi Industrial Investment Group to expand its production capacity. These regions offer significant opportunities for Single Cell Protein adoption in animal feed and potential human nutrition markets, contingent on the development of their regulatory frameworks.